Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.316
Delayed Data
As of Feb 08
 -0.014 / -4.24%
Today’s Change
0.20
Today|||52-Week Range
0.44
-22.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues1.4M1.2M2.2M2.7M
 
 
 
 
 
Cost of Goods Sold699.7K903.7K1.2M1.4M
 
 
 
 
 
Depreciation And Amortization213.0K--161.5K164.3K
 
 
 
 
 
Operating ExpensesGross Income450.3K330.5K804.7K1.1M
 
 
 
 
 
General Expenses3.0M5.9M3.2M5.1M
 
 
 
 
 
Research And Development2.3M4.8M2.4M4.2M
 
 
 
 
 
Total Operating Expenses3.9M6.8M4.6M6.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.6M-5.5M-2.4M-4.0M
 
 
 
 
 
Extraordinary Credit23.6M--7.2M2.1M
 
 
 
 
Extraordinary Charge---3.5M0.000.00
 
 
Interest Expense On Debt66.2K72.8K72.7K63.8K
 
 
 
 
 
Other Expenses0.007.00-2.8K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income21.0M-9.1M4.7M-1.9M
 
 
 
 
 
Net Income21.0M-9.1M11.2M-7.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS601.1M631.1M646.9M665.3M
 
 
 
 
 
Shares To Calculate EPS Diluted770.6M631.1M812.6M823.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$0.01$0.00$0.00
 
 
EPS Diluted-$0.00-$0.01$0.01-$0.01